Cargando…
Effects of tamoxifen inducible MerCreMer on gene expression in cardiac myocytes in mice
The Cre-LoxP technology, including the tamoxifen (TAM) inducible MerCreMer (MCM), is increasingly used to delineate gene function, understand the disease mechanisms, and test therapeutic interventions. We set to determine the effects of TAM-MCM on cardiac myocyte transcriptome. Expression of the MCM...
Autores principales: | Rouhi, Leila, Fan, Siyang, Cheedipudi, Sirisha M., Olcum, Melis, Jeong, Hyun-Hwan, Zhao, Zhongming, Gurha, Priyatansh, Marian, Ali J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785140/ https://www.ncbi.nlm.nih.gov/pubmed/35079750 http://dx.doi.org/10.20517/jca.2021.30 |
Ejemplares similares
-
The WNT/β-catenin pathway regulates expression of the genes involved in cell cycle progression and mitochondrial oxidative phosphorylation in the postmitotic cardiac myocytes
por: Olcum, Melis, et al.
Publicado: (2022) -
Generation of NSE-MerCreMer Transgenic Mice with Tamoxifen Inducible Cre Activity in Neurons
por: Kam, Mandy Ka Man, et al.
Publicado: (2012) -
4-hydroxytamoxifen does not deteriorate cardiac function in cardiomyocyte-specific MerCreMer transgenic mice
por: Heinen, Andre, et al.
Publicado: (2021) -
A Murine Myh6(MerCreMer) Knock-In Allele Specifically Mediates Temporal Genetic Deletion in Cardiomyocytes after Tamoxifen Induction
por: Yan, Jianyun, et al.
Publicado: (2015) -
Moderate and high amounts of tamoxifen in αMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death
por: Bersell, Kevin, et al.
Publicado: (2013)